Prof. Neil Hawkins MSc, MBA, PhD, CStat
Partner, Director of Health Technology Assessment
Neil is a Chartered Statistician and Health Economist. He has held leadership roles in the pharma, academic, and consultancy sectors within epidemiology, clinical development, and health technology assessment.
He is currently a partner in Visible Analytics Ltd and a Professor in Health Technology Assessment (HTA) at the University of Glasgow, UK. Previously he was Vice President leading the global Health Economics practice at ICON PLC (a global CRO) and a member of the board of directors at Oxford Outcomes Ltd.
He is also Vice Chair of the National Institute of Health and Clinical Excellence Diagnostics Assessment Committee and a member of the Medical Technologies Advisory Committee. He was a member of the Antimicrobials Evaluation Committee (2022) and the COVID-19 In-Vitro Data Expert Advisory Group (IVAG) and a member (2019-2021) of the Board of Directors of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR).
He acts as a consultant in HTA to the pharmaceutical and device industries providing advice spanning detailed analytic issues, policy perspectives, and board level strategy. His wide range of experience enables him to consider a wide range of stakeholder viewpoints and incentives while providing this advice.
Neil’s research and expertise focusses on, evidence synthesis and decision analytic modelling, application of precision medicine and assessment of subgroup effects, the assessment of healthcare technologies during early development, design of performance-based reimbursement schemes and the structure of capital markets for pharmaceutical development
Neil has conducted workshops discussing methods for evidence synthesis and decision analytic modelling in North and South America, Europe, Asia and Saudi Arabia and has developed ISPOR short courses covering Statistical Methods, Systematic Review and Meta-Analysis, and the Development of Conceptual Models. He has published over 120 articles in international journals such as Health Economics, Medical Decision Making, Journal of Clinical Epidemiology, Heart, and Value in Health.
Neil received a PhD in Pharmacology (University of Bristol), Master’s Degrees in Health Economics (York), Applied Statistics (Sheffield Hallam), and an MBA (University of Oxford) and is a Chartered Statistician (Royal Statistical Society, UK).
